Akers

AKER NASDAQ
0.6500
+0.0194
+3.08%
After Hours: 0.6500 0 0.00% 17:33 05/24 EDT
Open
0.6625
Prev Close
0.6306
High
0.6625
Low
0.6400
Volume
58.62K
Avg Vol (3M)
337.50K
52 Week High
4.880
52 Week Low
0.5700
% Turnover
0.47%
Market Cap
8.12M
1D
5D
1M
3M
1Y
5Y

Comments

No Data

Company Profile

Akers Biosciences, Inc. develops, manufactures and supplies point-of-care screening and testing products designed to bring health-related information to the patient or clinician. The Company's product offerings and pipeline products focus on delivering diagnostic assistance in a range of healthcare fields/specialties, including cardiology/emergency medicine, metabolism/nutrition, diabetes, respiratory diseases and infectious diseases detection, as well as for on and off-the-job alcohol safety initiatives. The Company's primary focus is the development and sale of disposable diagnostic testing devices that can be performed in minutes, to facilitate time sensitive therapeutic decisions. The Company's main products include a disposable breathalyzer test that measures the blood alcohol content of the user, a rapid test detecting the antibody causing an allergic reaction to Heparin and a disposable breathalyzer test that measures Free Radical activity in the human body.
MORE >

Recently

Name
Price
%Change